Literature DB >> 29217741

On the Reproducibility of Inversion Recovery Intravoxel Incoherent Motion Imaging in Cerebrovascular Disease.

S M Wong1,2, W H Backes1,2, C E Zhang3,2,4, J Staals3,4, R J van Oostenbrugge3,2,4, C R L P N Jeukens1, J F A Jansen5,2.   

Abstract

BACKGROUND AND
PURPOSE: Intravoxel incoherent motion imaging can measure both microvascular and parenchymal abnormalities simultaneously. The contamination of CSF signal can be suppressed using inversion recovery preparation. The clinical feasibility of inversion recovery-intravoxel incoherent motion imaging was investigated in patients with cerebrovascular disease by studying its reproducibility.
MATERIALS AND METHODS: Sixteen patients with cerebrovascular disease (66 ± 8 years of age) underwent inversion recovery-intravoxel incoherent motion imaging twice. The reproducibility of the perfusion volume fraction and parenchymal diffusivity was calculated with the coefficient of variation, intraclass correlation coefficient, and the repeatability coefficient. ROIs included the normal-appearing white matter, cortex, deep gray matter, white matter hyperintensities, and vascular lesions.
RESULTS: Values for the perfusion volume fraction ranged from 2.42 to 3.97 ×10-2 and for parenchymal diffusivity from 7.20 to 9.11 × 10-4 mm2/s, with higher values found in the white matter hyperintensities and vascular lesions. Coefficients of variation were <3.70% in normal-appearing tissue and <9.15% for lesions. Intraclass correlation coefficients were good to excellent, showing values ranging from 0.82 to 0.99 in all ROIs, except the deep gray matter and cortex, with intraclass correlation coefficients of 0.66 and 0.54, respectively. The repeatability coefficients ranged from 0.15 to 0.96 × 10-2 and 0.10 to 0.37 × 10-4 mm2/s for perfusion volume fraction and parenchymal diffusivity, respectively.
CONCLUSIONS: Good reproducibility of inversion recovery-intravoxel incoherent motion imaging was observed with low coefficients of variation and high intraclass correlation coefficients in normal-appearing tissue and lesion areas in cerebrovascular disease. Good reproducibility of inversion recovery-intravoxel incoherent motion imaging in cerebrovascular disease is feasible in monitoring disease progression or treatment responses in the clinic.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 29217741      PMCID: PMC7410585          DOI: 10.3174/ajnr.A5474

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  24 in total

1.  Diffusion anisotropy in subcortical white matter and cortical gray matter: changes with aging and the role of CSF-suppression.

Authors:  Yusuf A Bhagat; Christian Beaulieu
Journal:  J Magn Reson Imaging       Date:  2004-08       Impact factor: 4.813

2.  The IVIM signal in the healthy cerebral gray matter: A play of spherical and non-spherical components.

Authors:  Tim Finkenstaedt; Markus Klarhoefer; Christian Eberhardt; Anton S Becker; Gustav Andreisek; Andreas Boss; Cristina Rossi
Journal:  Neuroimage       Date:  2017-03-03       Impact factor: 6.556

3.  Measuring subtle leakage of the blood-brain barrier in cerebrovascular disease with DCE-MRI: Test-retest reproducibility and its influencing factors.

Authors:  Sau May Wong; Jacobus F A Jansen; C Eleana Zhang; Julie Staals; Paul A M Hofman; Robert J van Oostenbrugge; Cécile R L P N Jeukens; Walter H Backes
Journal:  J Magn Reson Imaging       Date:  2017-02-03       Impact factor: 4.813

4.  Intravoxel incoherent motion diffusion-weighted imaging in stroke patients: initial clinical experience.

Authors:  Y Yao; S Zhang; X Tang; S Zhang; J Shi; W Zhu; W Zhu
Journal:  Clin Radiol       Date:  2016-05-19       Impact factor: 2.350

5.  Intravoxel incoherent motion diffusion-weighted MR imaging of gliomas: feasibility of the method and initial results.

Authors:  Sotirios Bisdas; Tong San Koh; Constantin Roder; Christian Braun; Jens Schittenhelm; Ulrike Ernemann; Uwe Klose
Journal:  Neuroradiology       Date:  2013-07-14       Impact factor: 2.804

6.  Cerebral spinal fluid contamination of the measurement of the apparent diffusion coefficient of water in acute stroke.

Authors:  Lawrence L Latour; Steven Warach
Journal:  Magn Reson Med       Date:  2002-09       Impact factor: 4.668

7.  Reproducibility of quantitative cerebral T2 relaxometry, diffusion tensor imaging, and 1H magnetic resonance spectroscopy at 3.0 Tesla.

Authors:  Jacobus F A Jansen; M Eline Kooi; Alfons G H Kessels; Klaas Nicolay; Walter H Backes
Journal:  Invest Radiol       Date:  2007-06       Impact factor: 6.016

Review 8.  Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia.

Authors:  David C Alsop; John A Detre; Xavier Golay; Matthias Günther; Jeroen Hendrikse; Luis Hernandez-Garcia; Hanzhang Lu; Bradley J MacIntosh; Laura M Parkes; Marion Smits; Matthias J P van Osch; Danny J J Wang; Eric C Wong; Greg Zaharchuk
Journal:  Magn Reson Med       Date:  2014-04-08       Impact factor: 4.668

9.  Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain.

Authors:  Matthew Grech-Sollars; Patrick W Hales; Keiko Miyazaki; Felix Raschke; Daniel Rodriguez; Martin Wilson; Simrandip K Gill; Tina Banks; Dawn E Saunders; Jonathan D Clayden; Matt N Gwilliam; Thomas R Barrick; Paul S Morgan; Nigel P Davies; James Rossiter; Dorothee P Auer; Richard Grundy; Martin O Leach; Franklyn A Howe; Andrew C Peet; Chris A Clark
Journal:  NMR Biomed       Date:  2015-04       Impact factor: 4.044

10.  Simultaneous investigation of microvasculature and parenchyma in cerebral small vessel disease using intravoxel incoherent motion imaging.

Authors:  Sau May Wong; C Eleana Zhang; Frank C G van Bussel; Julie Staals; Cécile R L P N Jeukens; Paul A M Hofman; Robert J van Oostenbrugge; Walter H Backes; Jacobus F A Jansen
Journal:  Neuroimage Clin       Date:  2017-01-17       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.